NO975931D0 - Blanding for administrering av medikament - Google Patents

Blanding for administrering av medikament

Info

Publication number
NO975931D0
NO975931D0 NO975931A NO975931A NO975931D0 NO 975931 D0 NO975931 D0 NO 975931D0 NO 975931 A NO975931 A NO 975931A NO 975931 A NO975931 A NO 975931A NO 975931 D0 NO975931 D0 NO 975931D0
Authority
NO
Norway
Prior art keywords
administration
drug
mixture
Prior art date
Application number
NO975931A
Other languages
English (en)
Other versions
NO975931L (no
Inventor
Lisbeth Illum
Clive Washington
Simon Lawrence
Peter Watts
Original Assignee
Danibosyst Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danibosyst Uk Ltd filed Critical Danibosyst Uk Ltd
Publication of NO975931D0 publication Critical patent/NO975931D0/no
Publication of NO975931L publication Critical patent/NO975931L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO975931A 1995-07-20 1997-12-17 Blanding for administrering av medikament NO975931L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9514878.9A GB9514878D0 (en) 1995-07-20 1995-07-20 Vitamin E as a solubilizer for drugs contained in lipid vehicles
PCT/GB1996/001758 WO1997003651A1 (en) 1995-07-20 1996-07-22 Lipid vehicle drug delivery composition containing vitamin e

Publications (2)

Publication Number Publication Date
NO975931D0 true NO975931D0 (no) 1997-12-17
NO975931L NO975931L (no) 1997-12-17

Family

ID=10777989

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975931A NO975931L (no) 1995-07-20 1997-12-17 Blanding for administrering av medikament

Country Status (8)

Country Link
US (1) US20020025337A1 (no)
EP (1) EP0839025A1 (no)
JP (1) JPH11509545A (no)
AU (1) AU712621B2 (no)
CA (1) CA2224734A1 (no)
GB (1) GB9514878D0 (no)
NO (1) NO975931L (no)
WO (1) WO1997003651A1 (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964946B1 (en) * 1995-10-26 2005-11-15 Baker Norton Pharmaceuticals, Inc. Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
US6245805B1 (en) * 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
WO1998013359A1 (de) * 1996-09-24 1998-04-02 Marigen S.A. Ultramikroemulsionen aus spontan dispergierbaren konzentraten mit antitumoral und antiviral wirksamen estern von baccatin-iii-verbindungen
US20030105156A1 (en) * 1997-01-07 2003-06-05 Nagesh Palepu Method for administration of a taxane/tocopherol formulation to enhance taxane therapeutic utility
US6727280B2 (en) 1997-01-07 2004-04-27 Sonus Pharmaceuticals, Inc. Method for treating colorectal carcinoma using a taxane/tocopherol formulation
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
AR012627A1 (es) 1997-04-29 2000-11-08 Sherman Bernard Charles Pre-concentrado de emulsion que comprende una ciclosporina y monoglicerido acetilado
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
GB9715759D0 (en) * 1997-07-26 1997-10-01 Danbiosyst Uk New emulsion formulations
BR9814615A (pt) * 1997-10-22 2001-10-16 Jens Ponikau Métodos e materiais para o tratamento e prevenção de inflamação do tecido da mucosa
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
ES2211151T3 (es) * 1998-08-19 2004-07-01 Skyepharma Canada Inc. Dispersiones acuosas inyectables de propofol.
US6071952A (en) * 1998-12-02 2000-06-06 Mylan Pharmaceuticals, Inc. Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
US6638522B1 (en) * 1998-12-11 2003-10-28 Pharmasolutions, Inc. Microemulsion concentrate composition of cyclosporin
DE19859045A1 (de) 1998-12-21 2000-06-29 Fresenius Pharma Austria Gmbh Emulsion vom Typ Öl in Wasser mit Schutzwirkung gegen Peroxidationsschäden an menschlichen Organen, deren Herstellung und Verwendung
US6596306B1 (en) * 2000-07-07 2003-07-22 David Ho Sue San Ho Drug delivery system:formulation for fat-soluble drugs
US8067032B2 (en) * 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US6991781B2 (en) * 2001-01-17 2006-01-31 The Procter & Gamble Company Delivery of reactive agents via bi-layer structures for use in shelf-stable products
US6991809B2 (en) 2001-06-23 2006-01-31 Lyotropic Therapeutics, Inc. Particles with improved solubilization capacity
GB0116107D0 (en) * 2001-06-30 2001-08-22 West Pharm Serv Drug Res Ltd Pharmaceutical composition
AU2002337692B2 (en) 2001-09-26 2007-09-13 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
WO2003097027A1 (fr) * 2002-05-22 2003-11-27 Nihon Pharmaceutical Co., Ltd. Emulsion huile dans eau de 1-menthol
US20030219465A1 (en) * 2002-05-23 2003-11-27 Suresh Kumar Gidwani Composition for delivery of dithranol
US20040185068A1 (en) * 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
WO2004091506A2 (en) * 2003-04-10 2004-10-28 Ivax Research, Inc. Taxane-based compositions and methods of use
JP4098276B2 (ja) 2003-06-16 2008-06-11 花王株式会社 酸性水中油型乳化組成物
US20050074445A1 (en) * 2003-10-01 2005-04-07 Papas Andreas M. Alpha-tocopherol treatment for cystic fibrosis
NZ549016A (en) 2004-02-13 2012-03-30 Bioavailability Inc A microemulsion preparation of high concentration propofol for anesthetic uses
KR20070059072A (ko) * 2004-07-28 2007-06-11 에스디 파마슈티칼스 인코포레이티드 알파 토코페릴 석시네이트, 이의 동족체 및 이의 염의안정한 주사용 조성물
WO2008020318A2 (en) * 2006-03-30 2008-02-21 Engene, Inc. Non-viral compositions and methods for transfecting gut cells in vivo
JP5306626B2 (ja) * 2007-09-04 2013-10-02 オリザ油化株式会社 粉末製剤並びにそれを用いた食品素材及び化粧品素材
US20090291132A1 (en) * 2008-01-04 2009-11-26 Brian Charles Keller Enhanced delivery of antifungal agents
US20090176795A1 (en) * 2008-01-04 2009-07-09 Brian Charles Keller Enhanced delivery of antifungal agents
EP2204167A1 (en) 2009-01-05 2010-07-07 Azad Pharma AG Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules
US20100260830A1 (en) * 2009-04-08 2010-10-14 Brian A Salvatore Liposomal Formulations of Tocopheryl Amides
EP2768486B1 (en) * 2011-10-21 2018-10-03 First Tech International Limited Tocotrienol compositions
IN2014DN06911A (no) * 2012-01-31 2015-05-15 Santen Pharmaceutical Co Ltd
CN102525921B (zh) * 2012-02-06 2013-08-07 西安力邦制药有限公司 2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法
JP2013203680A (ja) * 2012-03-28 2013-10-07 Kobe Gakuin ビタミンｅ誘導体を含有する血中滞留性薬物キャリアー粒子
CN107249565A (zh) * 2015-02-27 2017-10-13 那野伽利阿株式会社 聚合物微团载体组合物和聚合物微团组合物
AU2021283774A1 (en) * 2020-06-04 2023-01-19 Hovid Berhad Composition for normalisation of fatty liver and method for producing the same
CN114344199A (zh) * 2022-02-26 2022-04-15 南京同仁堂健康产业有限公司 一种维生素e乳及其制备方法和应用、保湿霜及其制备方法
US11969434B1 (en) 2022-08-29 2024-04-30 Lipocine Inc. Oral allopregnanolone compositions and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3883246T2 (de) * 1987-10-19 1993-12-02 Liposome Co Inc Auf tocopherol basierte arzneimittelsysteme.
CA2013755C (en) * 1989-04-05 1993-11-30 Simon Benita Medicinal emulsions
US5478860A (en) * 1993-06-04 1995-12-26 Inex Pharmaceuticals Corp. Stable microemulsions for hydrophobic compound delivery
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions

Also Published As

Publication number Publication date
EP0839025A1 (en) 1998-05-06
WO1997003651A1 (en) 1997-02-06
AU6527596A (en) 1997-02-18
JPH11509545A (ja) 1999-08-24
CA2224734A1 (en) 1997-02-06
GB9514878D0 (en) 1995-09-20
NO975931L (no) 1997-12-17
US20020025337A1 (en) 2002-02-28
AU712621B2 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
NO975931D0 (no) Blanding for administrering av medikament
NO20001219D0 (no) Blanding for medikament-administrasjon
NO973938D0 (no) Farmasöytisk preparat av piperdinoalkanolforbindelser
IS4566A (is) Lyfjablanda til að gefa í gegnum húð
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
NO950238L (no) Blanding for tilförsel av legemiddel til lymfesystemet
NO980126L (no) Plaster-formulering for perkantal administrering av fenantyl
NO994757D0 (no) FramgangsmÕte for oral administrasjon av proteiner
FI972292A0 (fi) Administrering av diabetes
NO973250D0 (no) Preparater for avlevering av antigener
NO994003L (no) Farmasoytisk blanding
AU7294196A (en) Stable pharmaceutical forms of administration containing parathormone
NO970252L (no) Blanding for nasal administrering av et medikament
NO962231D0 (no) Prolegemidler av paclitaxelderivater
NO991733D0 (no) FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering
GB9601186D0 (en) Administration of Drugs
NO932860D0 (no) Fremgangsmaate for fremstilling av kalsium-l-askorbat-2-fosfat
NO981537L (no) FremgangsmÕte for fremstilling av antimalariamedikamenter
NO980384L (no) Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler
NO981798D0 (no) FremgangsmÕte for fremstilling av faste legemiddelformer
FI973277A0 (fi) Farmaseuttisia valmisteita TNF:n estämiseksi
NO974747D0 (no) Fremgangsmåte for fremstilling av streptograminer
FI940717A0 (fi) Streptogramiinien puhdistetut muodot, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
NO962809D0 (no) Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater
NO904470D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application